New research links gut bacteria molecule ImP to Alzheimer's disease changes. Higher ImP levels correlate with poorer cognitive scores and brain biomarkers. Experiments suggest ImP weakens the blood-brain barrier and affects brain cell processes. These findings offer clues about the gut-brain connection's influence on neurodegeneration. Scientists are exploring ways to reduce ImP production or block its effects.